These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23138649)

  • 1. Genes regulating the B cell receptor pathway are recurrently mutated in primary central nervous system lymphoma.
    Montesinos-Rongen M; Schäfer E; Siebert R; Deckert M
    Acta Neuropathol; 2012 Dec; 124(6):905-6. PubMed ID: 23138649
    [No Abstract]   [Full Text] [Related]  

  • 2. Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.
    Montesinos-Rongen M; Godlewska E; Brunn A; Wiestler OD; Siebert R; Deckert M
    Acta Neuropathol; 2011 Dec; 122(6):791-2. PubMed ID: 22020631
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.
    Montesinos-Rongen M; Küppers R; Schlüter D; Spieker T; Van Roost D; Schaller C; Reifenberger G; Wiestler OD; Deckert-Schlüter M
    Am J Pathol; 1999 Dec; 155(6):2077-86. PubMed ID: 10595937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor.
    Sugita Y; Terasaki M; Nakashima S; Ohshima K; Morioka M; Abe H
    Brain Tumor Pathol; 2015 Jan; 32(1):41-8. PubMed ID: 25433721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
    Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
    Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition.
    Varano G; Raffel S; Sormani M; Zanardi F; Lonardi S; Zasada C; Perucho L; Petrocelli V; Haake A; Lee AK; Bugatti M; Paul U; Van Anken E; Pasqualucci L; Rabadan R; Siebert R; Kempa S; Ponzoni M; Facchetti F; Rajewsky K; Casola S
    Nature; 2017 Jun; 546(7657):302-306. PubMed ID: 28562582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.
    Zuckerman NS; McCann KJ; Ottensmeier CH; Barak M; Shahaf G; Edelman H; Dunn-Walters D; Abraham RS; Stevenson FK; Mehr R
    Int Immunol; 2010 Nov; 22(11):875-87. PubMed ID: 21059768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade central nervous system lymphoma: clarity through a hazy lens.
    Hauser SL
    Ann Neurol; 2006 May; 59(5):9A-10A. PubMed ID: 16634011
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual variants of primary central nervous system lymphoma.
    Shenkier TN
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):651-64, vi. PubMed ID: 16083828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression in central nervous system lymphoma.
    Rubenstein JL; Shen A; Batchelor TT; Kadoch C; Treseler P; Shuman MA
    Blood; 2009 Jan; 113(1):266-7; author reply 267-8. PubMed ID: 19122120
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.
    De Paepe P; De Wolf-Peeters C
    Leukemia; 2007 Jan; 21(1):37-43. PubMed ID: 17039226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary CNS lymphoma.
    Hochberg FH; Baehring JM; Hochberg EP
    Nat Clin Pract Neurol; 2007 Jan; 3(1):24-35. PubMed ID: 17205072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the Network Lymphomas and Lymphomatoid Lesions in the Nervous System].
    Brück W; Brunn A; Klapper W; Kuhlmann T; Metz I; Paulus W; Deckert M;
    Pathologe; 2013 May; 34(3):186-97. PubMed ID: 23471726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
    Sugita Y; Tokunaga O; Nakashima A; Shigemori M
    Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
    Courts C; Montesinos-Rongen M; Martin-Subero JI; Brunn A; Siemer D; Zühlke-Jenisch R; Pels H; Jürgens A; Schlegel U; Schmidt-Wolf IG; Schaller C; Reifenberger G; Sabel M; Warnecke-Eberz U; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2007 Mar; 66(3):230-7. PubMed ID: 17356384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of reactive perivascular lymphocytic infiltrate in primary central nervous system lymphoma.
    Bhagavathi S
    J Postgrad Med; 2009; 55(4):240-1. PubMed ID: 20083867
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes.
    Levy R; Meeker T; Lowder J; Levy S; Thielemans K; Warnke RA; Cleary ML; Sklar J
    Symp Fundam Cancer Res; 1986; 38():261-8. PubMed ID: 3529276
    [No Abstract]   [Full Text] [Related]  

  • 18. TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium.
    Bruno A; Alentorn A; Daniau M; Labussière M; Rahimian A; Tabouret E; Polivka M; Jouvet A; Adam C; Figarella-Branger D; Chrétien F; Eimer S; Houillier C; Soussain C; Mokhtari K; Hoang-Xuan K
    Acta Neuropathol; 2015 Sep; 130(3):439-40. PubMed ID: 26195323
    [No Abstract]   [Full Text] [Related]  

  • 19. Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas.
    Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
    Oncology; 2006; 70(3):212-21. PubMed ID: 16809940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging insights into origin and pathobiology of primary central nervous system lymphoma.
    You H; Wei L; Kaminska B
    Cancer Lett; 2021 Jul; 509():121-129. PubMed ID: 33766752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.